Literature DB >> 19540928

siRNAs: their potential as therapeutic agents--Part I. Designing of siRNAs.

Praveensingh B Hajeri1, Sunit Kumar Singh.   

Abstract

RNA interference (RNAi) is a novel and essential biological process, as well as a powerful experimental tool with the potential to be used in therapeutic development. RNAi-based strategies have the capability of being able to be driven from bench to bedside. It is very important to develop the precise tools for designing the siRNAs to get the most efficient knockdown of the target genes and to reduce any off-target effects. In this review we have discussed the strategies and parameters required for effective siRNA designing and synthesis, based on already published literature.

Mesh:

Substances:

Year:  2009        PMID: 19540928     DOI: 10.1016/j.drudis.2009.06.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

Review 1.  Preclinical and clinical development of siRNA-based therapeutics.

Authors:  Gulnihal Ozcan; Bulent Ozpolat; Robert L Coleman; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

2.  Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells.

Authors:  A Paganin-Gioanni; E Bellard; J M Escoffre; M P Rols; J Teissié; M Golzio
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

3.  Sensor and sensitivity: a screen for elite shRNAs.

Authors:  Daniela Castanotto
Journal:  Mol Ther       Date:  2011-05       Impact factor: 11.454

4.  Inhibition of Respiratory Syncytial Virus Replication by Simultaneous Targeting of mRNA and Genomic RNA Using Dual-Targeting siRNAs.

Authors:  Somayeh Shatizadeh Malekshahi; Vahid Salimi; Ehsan Arefian; Ghazal Fatemi-Nasab; Sarvin Adjaminejad-Fard; Jila Yavarian; Talat Mokhtari-Azad
Journal:  Mol Biotechnol       Date:  2016-11       Impact factor: 2.695

5.  Single base mismatches in the mRNA target site allow specific seed region-mediated off-target binding of siRNA targeting human coagulation factor 7.

Authors:  Morgane Ravon; Marco Berrera; Martin Ebeling; Ulrich Certa
Journal:  RNA Biol       Date:  2012-01-01       Impact factor: 4.652

Review 6.  Genomic screening with RNAi: results and challenges.

Authors:  Stephanie Mohr; Chris Bakal; Norbert Perrimon
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

7.  HIVsirDB: a database of HIV inhibiting siRNAs.

Authors:  Atul Tyagi; Firoz Ahmed; Nishant Thakur; Arun Sharma; Gajendra P S Raghava; Manoj Kumar
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

8.  An efficient algorithm for systematic analysis of nucleotide strings suitable for siRNA design.

Authors:  Ancha Baranova; Jonathan Bode; Ganiraju Manyam; Maria Emelianenko
Journal:  BMC Res Notes       Date:  2011-05-27

9.  Potential siRNA Molecules for Nucleoprotein and M2/L Overlapping Region of Respiratory Syncytial Virus: In Silico Design.

Authors:  Somayeh Shatizadeh Malekshahi; Ehsan Arefian; Vahid Salimi; Talat Mokhtari Azad; Jila Yavarian
Journal:  Jundishapur J Microbiol       Date:  2016-04-23       Impact factor: 0.747

10.  RNAi knockdown of C-erbB2 expression inhibits salivary gland adenoid cystic carcinoma SACC-83 cell growth in vitro.

Authors:  Xiaohua Liu; Yincheng Zhang; Wenhao Ren; Tengteng Cao; Yongjin Zhu
Journal:  J Biomed Res       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.